Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1941.09% is 43% below its 5-year average of -1356.91%, around the middle of its 5-year range (-5654.34%–-32.01%).
1.52% above its 12-month average of -1971.03%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1448.56%.
NET PROFIT MARGIN
-1941.09%
NET PROFIT MARGIN AVG TTM
-1971.03%
NET PROFIT MARGIN AVG 3Y
-2179.04%
NET PROFIT MARGIN AVG 5Y
-1356.91%
NET PROFIT MARGIN AVG 10Y
-1167.73%
NET PROFIT MARGIN AVG 15Y
-1044.92%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.52%
CURRENT VS 3Y AVG
+10.92%
CURRENT VS 5Y AVG
-43.05%
CURRENT VS 10Y AVG
-66.23%
CURRENT VS 15Y AVG
-85.77%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-554497.14%
vs the sector median at left
Fate Therapeutics, Inc.
Market Cap
$266.92M
Net Profit Margin
-1941.09%
TTM Avg
-1971.03%
3Y Avg
-2179.04%
5Y Avg
-1356.91%
Market Cap
$266.59M
Net Profit Margin
0.00%
TTM Avg
-1289.52%
3Y Avg
-1135.48%
5Y Avg
-755.61%
Market Cap
$265.78M
Net Profit Margin
-10994.73%
TTM Avg
-520.92%
3Y Avg
-360.66%
5Y Avg
-288.77%
Market Cap
$264.25M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$270.80M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$262.92M
Net Profit Margin
-62.59%
TTM Avg
-99.90%
3Y Avg
-225.27%
5Y Avg
-207.41%
Market Cap
$271.81M
Net Profit Margin
-127.41%
TTM Avg
-55.77%
3Y Avg
-26.94%
5Y Avg
-14.34%
Market Cap
$261.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-5482.65%
5Y Avg
-3802.53%
Market Cap
$261.27M
Net Profit Margin
-568.80%
TTM Avg
-845.08%
3Y Avg
-422.54%
5Y Avg
-626.87%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc. (FATE) | $266.92M | -1941.09% | -1971.03% | -2179.04% | -1356.91% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $266.59M | 0.00% | -1289.52% | -1135.48% | -755.61% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $265.78M | -10994.73% | -520.92% | -360.66% | -288.77% |
| Scribe Therapeutics Inc. (SCTX)vs › | $264.25M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.80M | 0.00% | 0.00% | 0.00% | 0.00% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -62.59% | -99.90% | -225.27% | -207.41% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -127.41% | -55.77% | -26.94% | -14.34% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | 0.00% | 0.00% | -5482.65% | -3802.53% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -568.80% | -845.08% | -422.54% | -626.87% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | -43.70% | -35.13% | -15.36% | -13.33% |
Operating Margin
-2222.4%
Net Profit Margin
-1941.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1448.56% |
| 2026-03-31 | -2402.85% |
| 2025-12-31 | -2364.79% |
| 2025-09-30 | -1852.38% |
| 2025-06-30 | -1786.58% |
| 2025-03-31 | -2309.45% |
| 2024-12-31 | -2803.92% |
| 2024-09-30 | -1551.01% |
| 2024-06-30 | -567.44% |
| 2024-03-31 | -2493.71% |
| 2023-12-31 | -2632.58% |
| 2023-09-30 | -2323.56% |
| 2023-06-30 | -5654.34% |
| 2023-03-31 | -32.01% |
| 2022-12-31 | -127.07% |
| 2022-09-30 | -557.79% |
| 2022-06-30 | -410.29% |
| 2022-03-31 | -356.74% |
| 2021-12-31 | -402.02% |
| 2021-09-30 | -304.45% |
| 2021-06-30 | -411.07% |
| 2021-03-31 | -404.68% |
| 2020-12-31 | -334.12% |
| 2020-09-30 | -776.45% |
| 2020-06-30 | -513.67% |
| 2020-03-31 | -1332.80% |
| 2019-12-31 | -1010.06% |
| 2019-09-30 | -1095.47% |
| 2019-06-30 | -833.44% |
| 2019-03-31 | -750.76% |
| 2018-12-31 | -964.90% |
| 2018-09-30 | -1635.67% |
| 2018-06-30 | -1913.73% |
| 2018-03-31 | -1377.68% |
| 2017-12-31 | -1216.85% |
| 2017-09-30 | -1041.33% |
| 2017-06-30 | -940.06% |
| 2017-03-31 | -985.98% |
| 2016-12-31 | -773.13% |
| 2016-09-30 | -851.56% |
| 2016-06-30 | -818.70% |
| 2016-03-31 | -633.66% |
| 2015-12-31 | -692.01% |
| 2015-09-30 | -671.15% |
| 2015-06-30 | -2364.44% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 591.04% |
| 2013-09-30 | -2905.74% |
| 2013-06-30 | -1908.28% |
| 2013-03-31 | -751.69% |
| 2012-12-31 | -646.19% |
| 2012-09-30 | -778.98% |
